PDF(Pubmed)
Abstract：
OBJECTIVE: To capture UK medical students\' self-reported knowledge and harm assessment of psychedelics and to explore the factors associated with support for changing the legal status of psychedelics to facilitate further clinical research.
METHODS: Cross-sectional, anonymous online survey of UK medical students using a non-random sampling method.
METHODS: UK medical schools recognised by the General Medical Council.
METHODS: 132 medical students who had spent an average of 3.8 years (SD=1.4; range: 1-6) in medical school.
RESULTS: Most students (83%) reported that they were aware of psychedelic research and only four participants (3%) said that they were not interested in learning more about this type of research. Although medical students\' harm assessment of psychedelics closely aligned with that of experts, only 17% of students felt well-educated on psychedelic research. Teachings on psychedelics were only rarely encountered in their curriculum (psilocybin: 14.1 (SD=19.9), scale: 0 (never) to 100 (very often)). Time spent at medical schools was not associated with more knowledge about psychedelics (r=0.12, p=0.129). On average, this sample of medical students showed strong support for changing the legal status of psychedelics to facilitate further research into their potential clinical applications (psilocybin: 80.2 (SD=24.8), scale: 0 (strongly oppose) to 100 (strongly support)). Regression modelling indicated that greater knowledge of psychedelics (p<0.001), lower estimated harm scores (p<0.001), more time spent in medical school (p=0.024) and lower perceived effectiveness of non-pharmacological mental health treatments (p=0.044) were associated with greater support for legal status change.
CONCLUSIONS: Our findings reveal a significant interest among UK medical students to learn more about psychedelic research and a strong support for further psychedelic research. Future studies are needed to examine how medical education could be refined to adequately prepare medical students for a changing healthcare landscape in which psychedelic-assisted therapy could soon be implemented in clinical practice.
METHODS: Cross-sectional, anonymous online survey of UK medical students using a non-random sampling method.
METHODS: UK medical schools recognised by the General Medical Council.
METHODS: 132 medical students who had spent an average of 3.8 years (SD=1.4; range: 1-6) in medical school.
RESULTS: Most students (83%) reported that they were aware of psychedelic research and only four participants (3%) said that they were not interested in learning more about this type of research. Although medical students\' harm assessment of psychedelics closely aligned with that of experts, only 17% of students felt well-educated on psychedelic research. Teachings on psychedelics were only rarely encountered in their curriculum (psilocybin: 14.1 (SD=19.9), scale: 0 (never) to 100 (very often)). Time spent at medical schools was not associated with more knowledge about psychedelics (r=0.12, p=0.129). On average, this sample of medical students showed strong support for changing the legal status of psychedelics to facilitate further research into their potential clinical applications (psilocybin: 80.2 (SD=24.8), scale: 0 (strongly oppose) to 100 (strongly support)). Regression modelling indicated that greater knowledge of psychedelics (p<0.001), lower estimated harm scores (p<0.001), more time spent in medical school (p=0.024) and lower perceived effectiveness of non-pharmacological mental health treatments (p=0.044) were associated with greater support for legal status change.
CONCLUSIONS: Our findings reveal a significant interest among UK medical students to learn more about psychedelic research and a strong support for further psychedelic research. Future studies are needed to examine how medical education could be refined to adequately prepare medical students for a changing healthcare landscape in which psychedelic-assisted therapy could soon be implemented in clinical practice.
摘要：
目的：了解英国医学生对迷幻药的自我报告知识和危害评估，并探讨支持改变迷幻药法律地位的相关因素，以促进进一步的临床研究。
方法：横截面，使用非随机抽样方法对英国医学生进行匿名在线调查。
方法：获得总医学委员会认可的英国医学院。
方法：132名在医学院平均花费3.8年（SD=1.4；范围：1-6）的医学生。
结果：大多数学生（83％）报告说他们知道迷幻研究，只有四名参与者（3％）说他们对了解更多有关此类研究的信息不感兴趣。尽管医学生对迷幻药的伤害评估与专家的评估密切相关，只有17%的学生觉得在迷幻研究方面受过良好的教育。在他们的课程中很少遇到迷幻药的教学（psilocybin：14.1（SD=19.9），规模：0（从不）到100（经常））。在医学院度过的时间与更多关于迷幻药的知识无关（r=0.12，p=0.129）。平均而言,这些医学生的样本显示出强烈支持改变迷幻药的法律地位，以促进对其潜在临床应用的进一步研究（psilocybin：80.2（SD=24.8），规模：0（强烈反对）到100（强烈支持））。回归模型表明，对迷幻药有更多的了解(p<0.001)，较低的估计伤害得分(p<0.001)，在医学院花费的时间更多(p=0.024)和非药物精神卫生治疗的感知有效性更低(p=0.044)与对法律地位改变的更大支持相关.
结论：我们的发现揭示了英国医学生对了解更多迷幻研究的浓厚兴趣，并为进一步的迷幻研究提供了强有力的支持。未来的研究需要研究如何完善医学教育，以充分准备医学生为不断变化的医疗保健环境做好准备，在这种环境中，迷幻辅助治疗可以很快在临床实践中实施。
方法：横截面，使用非随机抽样方法对英国医学生进行匿名在线调查。
方法：获得总医学委员会认可的英国医学院。
方法：132名在医学院平均花费3.8年（SD=1.4；范围：1-6）的医学生。
结果：大多数学生（83％）报告说他们知道迷幻研究，只有四名参与者（3％）说他们对了解更多有关此类研究的信息不感兴趣。尽管医学生对迷幻药的伤害评估与专家的评估密切相关，只有17%的学生觉得在迷幻研究方面受过良好的教育。在他们的课程中很少遇到迷幻药的教学（psilocybin：14.1（SD=19.9），规模：0（从不）到100（经常））。在医学院度过的时间与更多关于迷幻药的知识无关（r=0.12，p=0.129）。平均而言,这些医学生的样本显示出强烈支持改变迷幻药的法律地位，以促进对其潜在临床应用的进一步研究（psilocybin：80.2（SD=24.8），规模：0（强烈反对）到100（强烈支持））。回归模型表明，对迷幻药有更多的了解(p<0.001)，较低的估计伤害得分(p<0.001)，在医学院花费的时间更多(p=0.024)和非药物精神卫生治疗的感知有效性更低(p=0.044)与对法律地位改变的更大支持相关.
结论：我们的发现揭示了英国医学生对了解更多迷幻研究的浓厚兴趣，并为进一步的迷幻研究提供了强有力的支持。未来的研究需要研究如何完善医学教育，以充分准备医学生为不断变化的医疗保健环境做好准备，在这种环境中，迷幻辅助治疗可以很快在临床实践中实施。
